Summary of WHO guidelines, policies, and statements on the treatment of DR-TB.

Guidelines for the treatment of DS-TB are not included because these have remained largely unchanged in this period. Key dates are also included from the case study of the STREAM trial, a trial comparing a 9- to 11-month regimen containing high-dose moxifloxacin and clofazimine with the 20- to 24-month WHO-recommended standard of care regimen for MDR-TB, which is discussed further in Box 1.

本数据集未纳入药物敏感肺结核（Drug-Susceptible Tuberculosis，DS-TB）的治疗指南，因该类指南在此阶段基本未发生变化。本数据集同时收录了STREAM临床试验的案例研究关键时间节点；该试验对比了含高剂量莫西沙星与氯法齐明的9至11个月治疗方案，以及世界卫生组织（WHO）推荐的耐多药肺结核（Multidrug-Resistant Tuberculosis，MDR-TB）标准治疗方案（时长20至24个月），相关内容将在方框1中进一步详述。